Search clinical trials for: Vasomotor Symptoms

Total 245335 results

Estetra
ICON Clinical Research

Completed

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort)

Vasomotor Symptoms | Menopausal Symptoms

United States, Canada
Wake Forest University Health Sciences

Completed

HIRREM Hot Flashes Study

Vasomotor Symptoms | Hot Flashes | Menopause

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women

Menopause Hot Flashes

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms

Vasomotor Symptoms (VMS)

United States
Bayer

Completed

A Study to Learn How Safe the Study Treatment Elinzanetant is and How it Moves Into, Through and Out of the Body When Given as Single Increasing Doses That Are Higher Than Normally Used Compared to Placebo and Moxifloxacin in Healthy Participants

Hot Flashes | Healthy Volunteers | Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Germany
Stefan Soderberg
University of Edinburgh

Completed

Leptin Infusion and Endothelial Vasomotor Response (LIVARM)

Obesity | Endothelial Dysfunction | Vasodilation | Venous Occlusion Plethysmography

Sweden, United Kingdom
Aylin Güneş

Completed

Determination of the Effects of Autogenic Relaxation Exercise and Cold Pillow Application on Vasomotor Symptom Control and Quality of Life in Postmenopausal Women (Vasomotor)

Quality of Life | Vasomotor Symptoms

Turkey
Acer Therapeutics Inc.

Completed

Dose-ranging, PK, Safety, Efficacy Study of Osanetant in Patients With Moderate/Severe VMS Associated With Menopause

Post-menopausal Vasomotor Symptoms

United States
Osijek University Hospital
Josip Juraj Strossmayer University of Osijek

Completed

Ultrasound Markers of Systemic Inflammation

Endothelial Dysfunction | Vascular Dilation | Inflammation Process | Vasomotor Arterial Disorder | Swelling; Hand

Croatia
Bayer
Nerre Therapeutics Ltd.

Completed

A Study of BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms (SWITCH-1)

Hot Flashes | Menopause | Night Waking

United States, Canada, United Kingdom
Astellas Pharma Europe Ltd.

Completed

A Survey About Hot Flashes in Women Going Through the Menopause

Vasomotor Symptoms | Menopause

United Kingdom
Daré Bioscience, Inc.

Completed

A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women

Vasomotor Symptoms | Vulvovaginal Atrophy

Australia
Bayer

Completed

A Study to Learn How the Study Drug Elinzanetant (BAY 3427080) Affects the Way the Drug Dabigatran Moves Into, Through and Out of the Body in Healthy Male and Female Participants

Hot Flashes | Healthy Volunteers | Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Germany
Ottawa Hospital Research Institute

Completed

Utilizing MyChart to Assess the Effectiveness of Interventions for Vasomotor Symptoms: A Feasibility Study

Breast Cancer

Canada
Bayer

Completed

A Study to Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally

Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

United States
ASCEND Therapeutics
Solvay Pharmaceuticals

Completed

Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy

Postmenopausal Symptoms

United States
Northwestern University
University of Illinois at Chicago; Indiana University

Terminated

Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer

Vasomotor Symptoms | Hot Flashes | Hot Flushes

United States
Bayer

Completed

A Study to Learn More About How the Study Treatment Elinzanetant (or BAY3427080) Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body After Taking Single and Multiple Doses in Healthy Women Aged 40 to 65 Years

Hot Flashes | Healthy Volunteers | Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

China
Hospital Regional 1o de Octubre
Universidad Nacional Autonoma de Mexico; National Polytechnic Institute, Mexico

Completed

Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome

Hot Flashes | Postmenopause

Mexico
Bayer

Completed

A Study to Learn More About How Much of the Study Treatment Elinzanetant (or BAY3427080) Gets Absorbed, How Safe it is and How it Affects the Body in Healthy Female and Male Participants

Hot Flashes | Healthy Volunteers | Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

United States
Bayer

Completed

A Study to Learn How Safe Elinzanetant is, How it Affects the Body, and How it Moves Into, Through and Out of the Body After Single and Multiple Doses in Japanese Healthy Female Adults

Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Japan
Bayer

Completed

A Study to Learn How Different Levels of Decreased Liver Function Influence Blood Levels of Elinzanetant Compared to Normal Liver Function in Male and Female Participants

Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Germany
Bayer

Completed

A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults

Hot Flashes | Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Netherlands
Bayer

Completed

A Study to Learn What Happens to Elinzanetant in the Body When Taken With or Without Carbamazepine, and How Safe it is in Healthy Men and Women Aged 18 to 60 Years.

Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Germany
Yung Shin Pharm. Ind. Co., Ltd.
Changhua Christian Hospital

Completed

A Study to Evaluate the Effects of RCN3028 on Moderate to Severe Vasomotor Symptoms in Women (RDC)

Hot Flashes | PMS

Taiwan
Sojournix, Inc.

Terminated

Phase 2 Study of SJX-653 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

Hot Flashes

Belgium, Germany, Poland, United Kingdom
Que Oncology
Syneos Health

Completed

Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor

Vasomotor Symptoms (VMS)

United States, New Zealand, Australia
Sidika Pelit Aksu

Completed

The Effect of Health Education and Progressive Muscle Relaxation Exercise on Vasomotor Symptoms and Sleep Problems With Perimenopausal Women

Vasomotor Symptoms | Hot Flashes | Sleep Problem

Turkey
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke (LA BICHAT)

Hypercholesterolemia | Cerebrovascular Accident

France
Bayer
Nerre Therapeutics Ltd.

Completed

Evaluation of the Pharmacokinetics and Safety of BAY3427080 (NT-814) in Post-Menopausal Women With Vasomotor Symptoms (RELENT-1)

Post-menopausal Vasomotor Symptoms

United States
Technische Universität Dresden
Michael J. Fox Foundation for Parkinson's Research; University Hospital Carl...

Completed

Effects of Heart Rate Variability Biofeedback in Patients With Acute Ischemic Stroke (Strokeback01)

Autonomic Dysfunction | Acute Ischaemic Stroke

Germany
Astellas Pharma Singapore Pte. Ltd.

Completed

A Survey Evaluating Prevalence, Severity and Associated Factors in East Asian Women With Moderate-to-severe Menopause-related Vasomotor Symptoms (MR-VMS)

Menopause

Korea, Republic of, China, Taiwan
Depomed

Completed

Breeze3:Study of Gabapentin Extended Release in the Treatment of Vasomotor Symptoms(Hot Flashes)in Postmenopausal Women (Breeze3)

Hot Flashes

United States
Universitaire Ziekenhuizen KU Leuven

Terminated

The Effect of Antimicrobial Therapy on the Serum Level of P-cresol in Peritoneal Dialysis Patients

Chronic Kidney Disease

Belgium
University of California, San Diego

Completed

Reproductive Health Survivorship Care Plan (SCPR)

Breast Cancer | Hot Flashes | Sexual Dysfunction | Contraception | Fertility

United States
Que Oncology

Completed

Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen

Vasomotor Symptoms (VMS)
University of British Columbia

Completed

Progesterone for Perimenopausal Night Sweats

Hot Flushes | Night Sweats

Canada
Massachusetts General Hospital
National Institute on Aging (NIA); Brigham and Women's Hospital

Completed

Gabapentin for Insomnia Symptoms and Nighttime Vasomotor Symptoms (VMS) in Peri- and Postmenopausal Women

Hot Flashes | Menopause | Vasomotor Disturbance

United States
University of Texas Southwestern Medical Center
AstraZeneca

Completed

Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial

Vasomotor Rhinitis

United States
Northwestern University

Completed

Pilot Study of Stellate Ganglion Injection to Provide Relief From Hot Flushes

Hot Flashes | Menopause

United States
TherapeuticsMD

Completed

A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms (REPLENISH)

Menopause

United States
Merck Sharp & Dohme LLC

Completed

Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)

Vasomotor Symptoms | Menopause | Postmenopausal Symptoms
Merck Sharp & Dohme LLC

Completed

Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012)

Vasomotor Symptoms | Menopause
St. Joseph's Healthcare Hamilton
Ontario Mental Health Foundation

Completed

Cognitive Behavioural Therapy for Menopausal Symptoms (CBTMENO)

Menopausal Depression

Canada
Radius Pharmaceuticals, Inc.

Terminated

Study to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

Vasomotor Symptoms | Hot Flashes

United States
BHR Pharma, LLC

Terminated

Study of Progesterone in Treatment of Vasomotor Symptoms (PROGEST)

Menopause Related Conditions

Germany
Amgen

Completed

Study of Erenumab (AMG 334) in Women With Hot Flashes

Vasomotor Symptoms; Hot Flashes

United States
Fervent Pharmaceuticals
Iqvia Pty Ltd

Completed

FP-101 for the Treatment of Hot Flashes in Postmenopausal Women

Hot Flashes

United States
Radius Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Effects of RAD1901 in the Treatment of Vasomotor Symptoms in Postmenopausal Women

Hot Flashes

United States
Merck Sharp & Dohme LLC

Terminated

A Study of MK-6913 for the Treatment of Hot Flashes in Postmenopausal Women (6913-004)

Women | Moderate to Severe Vasomotor Symptoms in Postmenopausal

3

Subscribe